Dr GSK Velu: We are the largest Indian medtech MNC

Dr GSK Velu, founder, Trivitron Group of Companies, India, speaks about how the firm has emerged as as the largest Indian multinational in medical technology with group revenues of $90 million in a span of just 15 years

Dr GSK Velu, founder, Trivitron Group of Companies, India

In span of 15 years, Trivitron has emerged as the largest Indian multinational in medical technology with group revenues of $90 million (Rs500 crore) for 2011-12. Trivitron offers a value chain of end-to-end solutions ranging from distribution to manufacturing and innovation in medical technology to the people of India, South Asia, South East Asia, Middle East and Africa.

Trivitron's focus areas are imaging diagnostics, laboratory diagnostics and cardiology (implantable device and equipment). It functions from across 17 offices (14 in India and three overseas), 10 warehouses and five manufacturing facilities in India with around 600 professionals. It has 400 channel partners, who have been successfully catering to various needs of healthcare providers across India. Trivitron has strategically partnered with global leaders in medical technology to bring the best to India. Recently, Trivitron entered into a partnership with Johari Digital to market physiotherapy products and point-of-care diagnostic products for global markets

Trivitron aims to become the most admired global medical technology player through innovation, manufacturing, comprehensive product solutions and world class customer service support. The company has taken initiatives such as commissioning South Asia's first medical technology park in Chennai in south India and Trivitron's innovation center at the IIT Madras. These are steps towards driving its vision of being a manufacturing leader in medical technology devices.

In an interview with BioSpectrum, Dr GSK Velu, founder, Trivitron Group of Companies, India, shared his views about the growth of the company, its future plans and competition in the medical technology market. Excerpts of the interview.

When you started Trivitron in 1997, what was the scenario of the Indian medical technology market? How do you see the market now? Market has always been import dependent, though now the percentage has dropped from almost 100 in 1990s to close to 80 percent in 2010. With an annual growth of around 15 percent and estimated medical technology industry revenue of about $6 billion in 2011, India ranks among the top three emerging nations for direct investment by large multi national medical technology companies.